DEVONIAN REPORTS ITS ANNUAL 2024 FINANCIAL RESULTS
PRESS RELEASE For immediate release DEVONIAN REPORTS ITS ANNUAL 2024 FINANCIAL RESULTS Fourth quarter revenues of $9 Million increased 749% year over year Annual revenues of $17.8 Million increased 660% year over year Fourth quarter net income of $007 per share Annual...
DEVONIAN ANNOUNCES THE GRANT OF STOCK OPTIONS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE GRANT OF STOCK OPTIONS QUÉBEC, October 8, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique...
DEVONIAN ANNOUNCES AMENDMENT TO ITS ARTICLES OF AMALGAMATION AND RESIGNATION OF ITS INTERIM CHIEF FINANCIAL OFFICER
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES AMENDMENT TO ITS ARTICLES OF AMALGAMATION AND RESIGNATION OF ITS INTERIM CHIEF FINANCIAL OFFICER Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, October 7,...
DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S CHICAGO VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 17, 2024
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S CHICAGO VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 17, 2024 Québec, QUÉBEC, July 15, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...
DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S LOS ANGELES VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 10, 2024
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S LOS ANGELES VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 10, 2024 Québec, QUÉBEC, July 8, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...
DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JUNE 26, 2024
PRESS RELEASE For immediate release DEVONIAN HEALTH GROUP TO PARTICIPATE IN RENMARK’S BOSTON VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, JULY 10, 2024 Québec, QUÉBEC, June 25, 2024 – Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB:...
Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm
PRESS RELEASE For immediate release Devonian Health Group Reports Third Quarter 2024 Financial Results and Business Update and Announces Engagement of Investor relations Firm Third quarter revenues increased 1,162% year over year Third quarter net loss for the quarter...
Devonian appoints André P. Boulet to Chairman of the Board and Chief Operating Officer
PRESS RELEASE For immediate release Devonian appoints André P. Boulet to Chairman of the Board and Chief Operating Officer Montreal, June 3, 2024 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage botanical...
Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update
PRESS RELEASE For immediate release Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update Quebec, Québec, March 28, 2024. Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), today announced financial...
Devonian Announces Closing of a Private Placement of Units
PRESS RELEASE For immediate release Devonian Announces Closing of a Private Placement of Units Not for distribution to United States newswire services or for dissemination in the United States QUÉBEC, March 14, 2024 – Devonian Health Group Inc. (“Devonian” or the...